A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This essential cancer inhibitor protein is frequently disabled in various kinds of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research